Incyte's drug Zynyz has become the first treatment specifically approved by the FDA for first-line anal cancer - four years after it was rejected by the regulators.
Dr. Laura Carlson has been named as the new interim president for the University of Delaware following the announcement of Dr. Dennis Assanis’ upcoming resignation.
The Diamond State Hospital Cost Review Board is grappling with the First State’s continuing trend of increasing health care expenditures following the release of the 2023 spending benchmark report.
The New Castle County Council is considering an increase in fees paid by developers on new construction to help support the added cost of county services five months after such a proposal was vetoed.
In the early months of 2025, the Wilmington office market saw a solid rebound as 60,000 square feet of leases were signed and vacancies hovered around 19%.
Joris Silon, U.S. Country President for AstraZeneca, talks about the need for a local supply chain in today's world during last week's Delaware's DNA Life Science Conference.
The Buccini/Pollin Group celebrated yet another start to an apartment complex with a groundbreaking ceremony – this time on the University of Delaware STAR Campus.
QPS Holdings, one of the first major Delaware bioscience companies that opened in the Delaware Technology Park, will launch a $16.6 million expansion project.
